RSV Antiviral Zelicapavir Enters Late-stage Clinical Trials
Enanta Pharma advanced zelicapavir into a registrational Phase 2b/3 clinical trial for adults at high risk of severe RSV outcomes.
Enanta Pharma advanced zelicapavir into a registrational Phase 2b/3 clinical trial for adults at high risk of severe RSV outcomes.
On July 1, international organizations aim to increase awareness and research for bronchiectasis to improve patient outcomes and healthcare access.
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
The software-as-a-medical-device allows for contactless measurement of respiratory and pulse rates using only a standard smartphone camera.
Phase 3 trial results indicate a new antifungal medication olorofim is as effective as current standard treatments for invasive aspergillosis with fewer side effects.
Hackensack Meridian Pascack Valley Medical Center successfully completed its first endobronchial ultrasound to diagnose pulmonary conditions.
Masimo's Radius VSM wearable monitor uses pattern recognition to help ID early signs of opioid-induced respiratory depression (OIRD).